Net Income

Recognized by TIME as a top global growth leader, GigaCloud isn't just collecting awards. Its success reveals a powerful B2B logistics model rewriting the rules.

Destination XL faces a perfect storm of declining sales, widening losses, and a crucial merger on the rocks. Can tech and new strategies counter market headwinds?

The appointment of Patrick Ramsey to the board of the new IGT-Everi entity is more than a personnel change; it's a strategic masterstroke. Here's why.

After weathering severe losses, Nebraska's FMNE Insurance rewrote its playbook. A $100M capital injection and aggressive strategy offer lessons for a risk-laden industry.

While others debate AI's future, CEO Eric Vaughan brings a radical playbook of M&A and cultural overhaul to the main stage, proving enterprise AI is here.

As The Conference Board honors S&P Global and UL Solutions, it’s clear that investing in people is no longer a soft skill—it's the core of modern strategy.

Bluejay Diagnostics secures critical funding to advance its rapid sepsis test, extending its cash runway but raising questions about shareholder dilution.

As its CEO heads to a top investor conference, Zealand Pharma leverages AI and novel peptides to challenge giants in the multi-billion-dollar obesity market.

A Florida firm's record mulch deliveries are more than just good news; they're a data-backed blueprint for the future of sustainable materials.

With a recent return to profitability and a booming EV charging division, Orion Energy Systems heads to a Vegas investor conference. Is this a new chapter?

As Americans face mounting financial pressure, a Depression-era model is re-emerging. We dive into why credit unions are the unsung heroes of affordability.

As AI and cyber risks escalate, the new 'Chief Trust Officer' role is emerging. HITRUST's appointment of a veteran leader signals a major shift for all.

QuadReal's appointment of Deloitte veteran Trevor Nakka signals a strategic pivot, adding elite financial governance to its $98.5B portfolio to fuel a disciplined global expansion.

Shake Shack's lowered guidance reveals a consumer trading down from premium burgers, a worrying sign for the entire fast-casual industry's health.

As Motorcar Parts of America preps its FY2026 report, investors await answers on declining revenue and the strategic review of its once-touted EV business.

JFrog's inclusion in the Russell 3000 isn't just a corporate win; it's a signal of the market's new respect for the software supply chain's vital role.

Pluri is moving its advanced cell-expansion tech from the lab to the lucrative U.S. aesthetics market. Is this a savvy commercial pivot or a risky gamble?

Aethlon Medical's upcoming financial report is more than a balance sheet; it's a test of viability for its revolutionary Hemopurifier blood filter.

Origin Agritech's gene-editing breakthrough allows corn to mature faster without sacrificing yield, a holy grail for breeders and a boon for global food security.

As global conflicts disrupt the world's helium, Pulsar Helium is accelerating a major new primary source in Minnesota, aided by new state laws and a rare ³He find.